Acasti Pharma Class A (NASDAQ:ACST) Shorted Shares Increased 151.22% After Market Selling


The stock of Acasti Pharma Class A (NASDAQ:ACST) registered an increase of 151.22% in short interest. ACST’s total short interest was 20,600 shares in September as published by FINRA. Its up 151.22% from 8,200 shares, reported previously. With 9,400 shares average volume, it will take short sellers 2 days to cover their ACST’s short positions. The short interest to Acasti Pharma Class A’s float is 0.38%. About 155 shares traded hands. Acasti Pharma Inc (NASDAQ:ACST) has declined 8.97% since February 8, 2016 and is downtrending. It has underperformed by 25.45% the S&P500.

Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $14.14 million. The Firm is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. It currently has negative earnings. The Firm is involved in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply